1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Trauma Global Clinical Trials Review, H2, 2015

Trauma Global Clinical Trials Review, H2, 2015

  • December 2015
  • -
  • GlobalData
  • -
  • 140 pages

Trauma Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Trauma Global Clinical Trials Review, H2, 2015" provides an overview of Trauma clinical trials scenario. This report provides top line data relating to the clinical trials on Trauma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Trauma Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Trauma to Other Diseases Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Trauma to Other Diseases Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Trauma Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 138
Abbreviations 138
Definitions 138
Research Methodology 139
Secondary Research 139
About GlobalData 140
Contact Us 140
Disclaimer 140
Source 140

List of Tables
Trauma Therapeutics, Global, Clinical Trials by Region, 2015* 6
Trauma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Trauma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Trauma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9
Trauma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Trauma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Trauma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 12
Trauma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Trauma to Other Diseases Clinical Trials, G7 Countries (%), 2015* 14
Trauma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Trauma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Trauma to Other Diseases Clinical Trials, E7 Countries (%), 2015* 17
Trauma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Trauma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Trauma Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Trauma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Trauma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Trauma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Trauma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Trauma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Trauma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Trauma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Trauma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

List of Figures
Trauma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Trauma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Trauma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Trauma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9
Trauma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Trauma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Trauma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 12
Trauma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13
Proportion of Trauma to Other Diseases Clinical Trials, G7 Countries (%), 2015* 14
Trauma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Trauma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Trauma to Other Diseases Clinical Trials, E7 Countries (%), 2015* 17
Trauma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Trauma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Trauma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Trauma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Trauma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Trauma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Trauma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Trauma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Trauma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Trauma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Trauma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 139

Companies mentioned
Novo A/S
Fresenius SE and Co. KGaA
Leucadia National Corporation
Nanotherapeutics, Inc.
CSL Limited
Baxter International Inc.
A. Carlsson Research AB
HealOr Ltd.
GlaxoSmithKline Plc
Johnson and Johnson

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation Summary Melanoma is a type of cancer that begins in the ...

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Breakthrough Therapies: Market Dynamics and Investment Opportunities

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Analyze the challenges and opportunities of developing breakthrough therapies, compare difference fast track drug development approaches and the potential risk and rewards of gaining ...

Alpha Mannosidosis Market and Enzyme Replacement Therapy - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Alpha Mannosidosis Market and Enzyme Replacement Therapy - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Alpha Mannosidosis Market: Overview With increase in the incidence of alpha mannosidosis worldwide the market for treatment is expected to grow in coming years. Alpha Mannosidosis is a rare inherited ...


Download Unlimited Documents from Trusted Public Sources

Opioid Market in China

  • March 2017
    4 pages
  • Opioid  

  • China  

View report >

Hormone and Therapy Market in Pakistan and the US

  • March 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Opioid Market in the US

  • March 2017
    24 pages
  • Opioid  

    Mortality  

  • United States  

    North America  

View report >

Therapy Market

2 days ago

Related Market Segments :

Therapy
Specialty Hospital

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.